New hope for rare hormone disorder: lu AG13909 enters human trials
NCT ID NCT05669950
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tests a new medicine called Lu AG13909 in 42 adults with congenital adrenal hyperplasia (CAH), a rare genetic condition that disrupts hormone production. The goal is to check the drug's safety, how the body processes it, and its effects on hormone levels. Participants will receive multiple doses, and researchers will monitor side effects and blood markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliero Universitaria di Bologna
RECRUITINGBologna, 40138, Italy
-
Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma
RECRUITINGRoma, 00161, Italy
-
Beaumont Hospital Royal College of Surgeons in Ireland (RCSI), Dublin
RECRUITINGDublin, D02 YN77, Ireland
-
CHRU Strasbourg
RECRUITINGStrasbourg, 67091, France
-
CHU de Lille
RECRUITINGLille, 59000, France
-
Cambridge Clinical Research Centre
RECRUITINGCambridge, CB2 0SL, United Kingdom
-
Centrum Nowoczesnych Terapii, Dobry Lekarz
RECRUITINGDobry Lekarz, 60-324, Poland
-
Chu Angers
RECRUITINGAngers, 49933, France
-
David Metreveli Medical Centre, Tbilisi
RECRUITINGTbilisi, 0144, Georgia
-
GH Pitié-Salpêtrière
RECRUITINGParis, 75013, France
-
Karolinska University Hospital
RECRUITINGStockholm, 17174, Sweden
-
NIHR Clinical Research Facility
RECRUITINGLondon, SE1 9RT, United Kingdom
-
NIHR/Wellcome Trust Clinical Research Facility
RECRUITINGBirmingham, B15 2TH, United Kingdom
-
Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, 413 45, Sweden
-
University College London Hospital - NIHR
RECRUITINGLondon, W1T 7HA, United Kingdom
-
University Hospital-University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.